Recombinant Human Granulocyte/Macrophage Colonystimulating Factor（rhGM-CSF）

Generic Name: Recombinant Human Granulocyte/Macrophage Colonystimulating Factor（rhGM-CSF）

Brand Names: -

Drug Type: -

Chemical Formula: -

CAS Number: -

Unique Ingredient Identifier: -

Indication: 用于：1.恶性肿瘤、白血病化、放疗引起的白血病减少及其并发的感染；

2.造血干/祖细胞移植后髓系造血功能受抑及延迟植活与移植排斥；

3.与rhG-CSF等造血生长因子联合或单独应用于外周血造血干/祖细胞移植前的干/祖细胞动员；

4.再生障碍性贫血等骨髓衰竭性疾患及各种严重感染并发的中性粒细胞减少；

5.也可用于艾滋病本身、或因药物治疗所致的中性粒细胞减少。

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Replimune Announces Positive Pre-BLA Meeting with FDA

Replimune Group, Inc. completed a successful pre-BLA meeting with the FDA, supporting plans to submit a BLA for RP1 in anti-PD1 failed melanoma via the accelerated approval pathway in 2H 2024. RP1, Replimune’s lead product candidate, is engineered to maximize tumor killing potency and immunogenicity.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy